eLife (Jan 2016)

ILC3 GM-CSF production and mobilisation orchestrate acute intestinal inflammation

  • Claire Pearson,
  • Emily E Thornton,
  • Brent McKenzie,
  • Anna-Lena Schaupp,
  • Nicky Huskens,
  • Thibault Griseri,
  • Nathaniel West,
  • Sim Tung,
  • Benedict P Seddon,
  • Holm H Uhlig,
  • Fiona Powrie

DOI
https://doi.org/10.7554/eLife.10066
Journal volume & issue
Vol. 5

Abstract

Read online

Innate lymphoid cells (ILCs) contribute to host defence and tissue repair but can induce immunopathology. Recent work has revealed tissue-specific roles for ILCs; however, the question of how a small population has large effects on immune homeostasis remains unclear. We identify two mechanisms that ILC3s utilise to exert their effects within intestinal tissue. ILC-driven colitis depends on production of granulocyte macrophage-colony stimulating factor (GM-CSF), which recruits and maintains intestinal inflammatory monocytes. ILCs present in the intestine also enter and exit cryptopatches in a highly dynamic process. During colitis, ILC3s mobilize from cryptopatches, a process that can be inhibited by blocking GM-CSF, and mobilization precedes inflammatory foci elsewhere in the tissue. Together these data identify the IL-23R/GM-CSF axis within ILC3 as a key control point in the accumulation of innate effector cells in the intestine and in the spatio-temporal dynamics of ILCs in the intestinal inflammatory response.

Keywords